Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section
Status:
Unknown status
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
It is a multicenter randomized, double-blind and placebo-controlled trial. Totally 6500 women
to delivery by cesarean section will be recruited in this study. In addition to routinely
oxytocin, the women in study group will receive TXA 1 g in 2 minutes after they delivered
their babies, and those in control group will receive placebo. The incidence of postpartum
hemorrhage, the amount of bleeding, as well as the side effects will be observed.